1 completed, 1 recruiting, 1 terminated, 1 withdrawn. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 1, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Heart Attack: new trials by email Literature Review of Heart Attack trials Research Report on Heart Attack
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI SGLT-2 inhibitors, Placebo - Heart Attack, Enlarged Heart | Phase 2 | Recruiting | Minneapolis Heart Institute Foundation | 81 | 2022-08-03 | 2024-10-08 |
| SINGaporean Program Performed With an eXPANsion Medical Device (SingXpand) Protheracytes - Heart Attack | Phase 1 / Phase 2 | Withdrawn | CellProthera | 2018-11-27 | 2022-06-10 | |
| A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction AMI MultiStem cells, Sham - Heart Attack, NSTEMI | Phase 2 | Terminated | Healios K.K. | 34 | 2015-12-01 | 2021-07-22 |
| IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting Injection of autologous CD133+ stem cells at the time of coronary artery bypass grafting - Heart Failure, Heart Attack | Phase 2 | Completed | University Health Network, Toronto | 20 | 2011-09-01 | 2015-12-02 |
Myocardial Infarction (4) · Cardiomegaly (1) · Heart Failure (1) · Non-ST Elevated Myocardial Infarction (1)
Cardiovascular Diseases (4) · Heart Diseases (4) · Infarction (4) · Ischemia (4) · Myocardial Ischemia (4) · Necrosis (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Vascular Diseases (4) · Hypertrophy (1) · Pathological Conditions, Anatomical (1)
AC133 Antigen (1) · Sodium-Glucose Transporter 2 Inhibitors (1) · salicylhydroxamic acid (1)
CellProthera (1) · Healios K.K. (1) · Minneapolis Heart Institute Foundation (1) · University Health Network, Toronto (1)
United States (2) · Canada (1) · Singapore (1)
Frederic Flandrin (1) · Jay Traverse, MD (1) · Marc Penn, MD (1) · Terrence M Yau, MD (1)
R44HL117572 (1)